Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure

SIMPLE SUMMARY: This review compiles our current knowledge of one of the main pathways activated by tumors to escape immune attack. Indeed, it integrates the current understanding of how tumor-derived circulating galectins affect the elicitation of effective anti-tumor immunity. It focuses on severa...

Descripción completa

Detalles Bibliográficos
Autores principales: Laderach, Diego José, Compagno, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469970/
https://www.ncbi.nlm.nih.gov/pubmed/34572756
http://dx.doi.org/10.3390/cancers13184529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469970/
https://www.ncbi.nlm.nih.gov/pubmed/34572756
http://dx.doi.org/10.3390/cancers13184529

Ejemplares similares